Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Publication year range
1.
Fertil Steril ; 94(6): 2107-12, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20117767

ABSTRACT

OBJECTIVE: To analyze the characteristics of patients with testicular germ cell cancer and compare patients' sperm quality according to histologic type (seminomatous and nonseminomatous tumors). DESIGN: Prospective study. SETTING: Sperm bank at a university. PATIENT(S): One hundred consecutive patients with testicular tumor who had been referred to our infertility center for cryopreservation, between 2004 and 2006. INTERVENTION(S): A questionnaire, through personal interview, was given to all patients and collection of seminal data before cryopreservation was performed. MAIN OUTCOME MEASURE(S): Patient characteristics, including age, time between diagnosis and orchiectomy, history of cryptorchidism, histologic type, and seminal analysis were taken into consideration. RESULT(S): The mean age of the patients at the time of diagnosis was 26.9 years. The mean time between cancer suspicion and the diagnosis of neoplasm was 58.9 days, and 19.4 more days were necessary until orchiectomy was performed. Eleven patients had a history of cryptorchidism. Thirty-seven patients had seminomatous tumors. Men with a seminoma present a higher number of motile and morphologically normal sperm in the ejaculate than men with a nonseminoma, although individual semen variables are not different. CONCLUSION(S): The majority of the patients with testicular cancer, referred to our infertility center, are very young, single, do not have children, and are unaware of their fertility potential status by the time diagnosis is made. Men with a nonseminoma present semen of lower quality.


Subject(s)
Individuality , Neoplasms, Germ Cell and Embryonal/physiopathology , Semen Analysis , Semen/physiology , Testicular Neoplasms/physiopathology , Adult , Age Factors , Awareness/physiology , Humans , Infertility, Male/diagnosis , Infertility, Male/epidemiology , Infertility, Male/etiology , Male , Neoplasms, Germ Cell and Embryonal/complications , Neoplasms, Germ Cell and Embryonal/diagnosis , Neoplasms, Germ Cell and Embryonal/epidemiology , Seminoma/complications , Seminoma/diagnosis , Seminoma/epidemiology , Seminoma/physiopathology , Surveys and Questionnaires , Testicular Neoplasms/complications , Testicular Neoplasms/diagnosis , Testicular Neoplasms/epidemiology , Young Adult
2.
Ginecol Obstet Mex ; 75(1): 46-9, 2007 Jan.
Article in Spanish | MEDLINE | ID: mdl-17542269

ABSTRACT

Males are affected from primary extragonadal germ cell tumors with a frequency of 2 to 5%. There is a high incidence of infertility of more than 60% and most of the cases have azoospermia due to testicular damage. The hormonal profile of these patients shows normal luteinizing hormone, normal follicle stimulating hormone and normal testosterone and estradiol. We communicate the case of a male who had a primary retroperitoneal germ cell tumor with a low title of chorionic gonadotropin, elevated estradiol and normal testosterone, prolactin and seminogram. Before beginning treatment with chemotherapy, his wife became pregnant delivering twins, both males. The patient was treated with chemo and radiotherapy after which he became azoospermic with an increase in both luteinizing hormone and follicle stimulating, decreased levels of estradiol and without alteration in prolactin and testosterone. The pituitary testicle axis was affected by the tumor, but the microenvironment of the testicles did not seem to be damaged only after initiating treatment.


Subject(s)
Retroperitoneal Neoplasms/physiopathology , Seminoma/physiopathology , Testis/physiopathology , Adult , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Azoospermia/blood , Azoospermia/etiology , Chorionic Gonadotropin/blood , Cisplatin/administration & dosage , Cisplatin/adverse effects , Combined Modality Therapy , Cyclophosphamide/administration & dosage , Cyclophosphamide/adverse effects , Female , Fertility , Follicle Stimulating Hormone/blood , Humans , Hypothalamo-Hypophyseal System/physiology , Infant, Newborn , Luteinizing Hormone/blood , Male , Pregnancy , Pregnancy, Multiple , Radiotherapy, Adjuvant/adverse effects , Retroperitoneal Neoplasms/drug therapy , Retroperitoneal Neoplasms/radiotherapy , Seminoma/drug therapy , Seminoma/radiotherapy , Testosterone/blood , Twins
SELECTION OF CITATIONS
SEARCH DETAIL